Is this you? Create Your Porfile
Avatar

Matsumoto Toshio

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Matsumoto Toshio is active.

Explore More

Publication

Featured researches published by Matsumoto Toshio.

Archive | 2006

IMMUNOTHERAPEUTIC AGENT AGAINST MULTIPLE MYELOMA, LEUKEMIA, MALIGNANT LYMPHOMA, LUNG CANCER OR THE LIKE

Ozaki Shuji; Matsumoto Toshio

PLOS ONE | 2013

Terminally differentiated OBs induce MM cell apoptosis with G 1 arrest.

Takeuchi Kyoko; Abe Masahiro; Hiasa Masahiro; Oda Asuka; Amou Hiroe; Kido Shinsuke; Harada Takeshi; Tanaka Osamu; Miki Hirokazu; Nakamura Shingen; Nakano Ayako; Kagawa Kumiko; Yata Kenichiro; Ozaki Shuji; Matsumoto Toshio

Archive | 2013

agente terapÊutico para cÂncer resistente a agentes quimioterÁpicos, potencializador de um agente quimoterÁpico, composiÇço farmacÊutica, e uso de um anticorpo capaz de reconhecer hla classe i

Matsumoto Toshio; Abe Masahiro; Ozaki Shuji

Archive | 2012

NOVEL MEDICAL UTILIZING ANTI-HLA ANTIBODY

Matsumoto Toshio; Ozaki Shuji; Abe Masahiro

Archive | 2011

COMPOSICIONES FARMACEUTICAS PARA TERAPIAS DE MANTENIMIENTO QUE CONTIENEN COMO INGREDIENTE ACTIVO UN ANTICUERPO QUE RECONOCE EL ANTIGENO LEUCOCITARIO HUMANO (HLA) DE CLASE I

Matsumoto Toshio; Abe Masahiro; Ozaki Shuji; Itoh Kohji; Tsuji Daisuke

Archive | 2011

TREATMENT OF ISCHEMIC DISEASE USING ERYTHROPOIETIN MOBILISED MONONUCLEAR CELLS

Matsumoto Toshio; Kitagawa Tetsuya; Abe Masahiro; Akaike Masashi; Nagayoshi Kazunari; Yamamoto Kaname; Higuchi Masato

Archive | 2011

tratamento de doenças isquêmicas usando eritropoietina

Matsumoto Toshio; Kitagawa Tetsuya; Abe Masahiro; Akaike Masashi; Nagayoshi Kazunari; Yamamoto Kaname; Higuchi Masato

Archive | 2011

Pharmaceutical compositions for maintenance therapy containing HLA class I-recognizing antibody as the active ingredient

Matsumoto Toshio; Abe Masahiro; Ozaki Shuji; Itoh Kohji; Tsuji Daisuke

Archive | 2009

AGENTES TERAPEUTICOS PARA CANCERES RESISTENTES A AGENTES QUIMIOTERAPEUTICOS QUE INCLUYEN COMO INGREDIENTE ACTIVO UN ANTICUERPO QUE RECONOCE HLA DE CLASE I Y SUS USOS

Matsumoto Toshio; Abe Masahiro; Ozaki Shuji

Archive | 2009

Behandling av ischemisks sykdommer ved bruk av erytropoietin

Matsumoto Toshio; Kitagawa Tetsuya; Abe Masahiro; Akaike Masashi; Nagayoshi Kazunari; Yamamoto Kaname; Higuchi Masato

Explore More

Collaboration

Dive into the Matsumoto Toshio's collaboration.

Explore More
Researchain Logo
Decentralizing Knowledge